Premium
Screening for prostatic cancer and its evolution within Britain
Author(s) -
Parkinson M. C.,
Bott S. R. J.,
Montironi R.,
Melia J.
Publication year - 2002
Publication title -
the journal of pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.964
H-Index - 184
eISSN - 1096-9896
pISSN - 0022-3417
DOI - 10.1002/path.1088
Subject(s) - prostate cancer , workload , cancer , medicine , gynecology , cancer detection , prostate , histopathology , prostate cancer screening , prostate specific antigen , pathology , computer science , operating system
The arguments for and against screening for prostatic cancer are frequently discussed (Albertsen PC. Screening for prostate cancer is neither appropriate nor cost‐effective. Urol Clin North Am 1996; 23 : 521–530; Schroder FH, Alexander FE, Bangma CH, Hugosson J, Smith DS. Screening and early detection of prostate cancer. Prostate 2000; 44 : 255–263). In contrast, this paper outlines how screening became possible, why the decision was made not to initiate a national screening programme in Britain, the other pathways being pursued, and the current problems, in particular the issue of histopathology workload. Copyright © 2002 John Wiley & Sons, Ltd.